Press Releases
These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
May 4, 2023DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital health market, today announced that it would release its financial results for the first quarter ended March 31, 2023, on Thursday,...
- May 2, 2023
Newly designated convertible preferred stock priced at the market under Nasdaq rules with significant participation by select members of leadership, the Board and existing investors Company also...
- Apr 4, 2023
Dario also appoints digital veteran, Arnaud Robert, to the role of Strategic Advisor to the Chief Executive Officer The appointments strengthen Dario's ability to scale its digital therapeutics...
- Mar 27, 2023
New agreement is the first contract resulting from strategic partnership with Sanofi NEW YORK, March 27, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader...
- Mar 22, 2023
New agreement integrates Dario's cardiometabolic suite into Amwell's market leading digital care delivery enablement platform covering over 90 million lives NEW YORK, March 22, 2023 /PRNewswire/...
- Mar 14, 2023
Dario's musculoskeletal solution uses data from a biofeedback sensor to drive healthier behaviors and reduce pain NEW YORK, March 14, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO)(the...
- Mar 9, 2023
Continued to improve the financial profile of the Company Full-year 2022 revenue of $27.7 million increased 34.8% over $20.5 million in 2021, as B2B revenue growth more than offset managed...
- Mar 2, 2023
DarioHealth Corp. (NASDAQ: DRIO), a leader in the global digital therapeutics (DTx) market, today announced it would release its financial results for the fourth quarter and year ended December...
- Feb 27, 2023
Dario demonstrates the impact of targeted coaching interventions in a digital-first chronic care solution Dario solution demonstrates significant impact on hypoglycemic events in senior...
- Feb 24, 2023
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced that management will participate in the Cowen 43nd Annual Healthcare Conference, which...
- Feb 23, 2023
Mr. Kaplan brings a wealth of experience in business strategy specifically in healthcare and digital health NEW YORK, Feb. 23, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) (the...
- Feb 8, 2023
New integration will improve access to Dario's multi-chronic platform for more people living with diabetes NEW YORK, Feb. 8, 2023 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) (the "Company"),...
- Feb 6, 2023
Preliminary Results demonstrate success in B2C to B2B transformation Total revenue for the year is expected to be $27.5 million compared to $20.5 million in 2021. B2B expected to represent...
- Jan 24, 2023
Matt Alberico joins Dario to help manage expanding growth opportunities after successfully driving customer growth at Amazon Care, Cigna and Aetna NEW YORK, Jan. 24, 2023 /PRNewswire/ --...
- Jan 9, 2023
DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital therapeutics (DTx) market, announced today the publication of new research in the peer-reviewed journal...
- Jan 3, 2023
Northeast supermarket chain will deploy Dario's cardiometabolic suite in 2023 NEW YORK, Jan. 3, 2023 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader in the...
- Dec 22, 2022
Dario Move to be deployed in Greece and Cyprus to help improve the musculoskeletal health of the general populations New York, Dec. 22, 2022 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) (the...
- Dec 19, 2022
DarioHealth Corp. (NASDAQ: DRIO) (the "Company"), a leader in the global digital therapeutics (DTx) market, announced the publication of a new study in the peer-reviewed journal Frontiers in...
- Dec 1, 2022
The new accounts originated through an existing relationship with a benefits brokerage and provide further validation of Dario's partnership Strategy. NEW YORK, Dec. 1, 2022 /PRNewswire/ --...
- Nov 16, 2022
DarioHealth Corp. (Nasdaq: DRIO) (the "Company"), a leader in the global digital therapeutics (DTx) market, announced today that management will participate at the following conferences: 13th...
- Nov 14, 2022
Third quarter 2022 revenues of $6.6 million increased 17.3% from $5.6 million in the third quarter of 2021 driven by growth in Business-to-Business (B2B) revenues. Nine-month year to date revenue...
- Nov 9, 2022
DarioHealth Corp. (NASDAQ: DRIO), a leader in the global digital therapeutics (DTx) market, today announced it would release its financial results for the third quarter ended September 30, 2022,...
- Oct 20, 2022
New 'jumbo' employer account represents increasing penetration of the Dario platform NEW YORK, Oct. 20, 2022 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO) ("Dario" or the "Company"), a leader...
-
Oct 13, 2022
Dario to support City employees with integrated solutions addressing diabetes, hypertension, weight management, musculoskeletal and behavioral health in company's first government contract win NEW...
Sep 22, 2022New research sheds light on the importance of training to drive healthier posture NEW YORK, Sept. 22, 2022 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leader in the global digital...